Go
View All
[Z78] - Other specified health status
[Z79.0] - Long term (current) use of anticoagulants and antithrombotics/antiplatelets
[Z79.01] - Long term (current) use of anticoagulants
[Z79.02] - Long term (current) use of antithrombotics/antiplatelets
[Z79.1] - Long term (current) use of non-steroidal anti-inflammatories (NSAID)
[Z79.2] - Long term (current) use of antibiotics
[Z79.3] - Long term (current) use of hormonal contraceptives
[Z79.4] - Long term (current) use of insulin
[Z79.5] - Long term (current) use of steroids
[Z79.51] - Long term (current) use of inhaled steroids
[Z79.52] - Long term (current) use of systemic steroids
[Z79.6] - Long term (current) use of immunomodulators and immunosuppressants
[Z79.60] - Long term (current) use of unspecified immunomodulators and immunosuppressants
[Z79.61] - Long term (current) use of immunomodulator
[Z79.62] - Long term (current) use of immunosuppressant
[Z79.620] - Long term (current) use of immunosuppressive biologic
[Z79.621] - Long term (current) use of calcineurin inhibitor
[Z79.622] - Long term (current) use of Janus kinase inhibitor
[Z79.623] - Long term (current) use of mammalian target of rapamycin (mTOR) inhibitor
[Z79.624] - Long term (current) use of inhibitors of nucleotide synthesis
[Z79.63] - Long term (current) use of chemotherapeutic agent
[Z79.630] - Long term (current) use of alkylating agent
[Z79.631] - Long term (current) use of antimetabolite agent
[Z79.632] - Long term (current) use of antitumor antibiotic
[Z79.633] - Long term (current) use of mitotic inhibitor
[Z79.634] - Long term (current) use of topoisomerase inhibitor
[Z79.64] - Long term (current) use of myelosuppressive agent
[Z79.69] - Long term (current) use of other immunomodulators and immunosuppressants
[Z79.8] - Other long term (current) drug therapy
[Z79.81] - Long term (current) use of agents affecting estrogen receptors and estrogen levels
Displaying items 49711 - 49740 of 50739